2m 2m 2m 2m 2m 2m 2m
Coherus Onco (CHRS)
NASDAQ
$1.48+$0.005 (+0.34%)
Price as of Jun 03, 2026 7:56 PM EDT- $245.3MMarket Cap
- 94.37%1-Year Change
- BiotechnologyIndustry
Coherus Onco (CHRS)
$1.48+$0.005 (+0.34%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 42.2M -84.20% | 267.0M +3.78% | 257.2M +21.89% | 211.0M -35.37% | |
Cost of Revenue | 13.8M -88.25% | 117.6M -26.06% | 159.0M +126.86% | 70.1M +21.69% | |
Gross Profit | 28.4M -81.02% | 149.4M +52.07% | 98.3M -30.30% | 141.0M -47.59% | |
Sales and Marketing Expense | 100.6M -40.02% | 167.7M -12.64% | 192.0M -3.26% | 198.5M +16.95% | |
Research and Development Expense | -108.9M +16.66% | -93.3M -14.71% | -109.4M -45.11% | -199.4M -45.10% | |
Depreciation and Amortization Expense | 3.9M -25.63% | 5.3M +39.17% | 3.8M +2.49% | 3.7M +7.09% | |
Total Operating Expenses | 223.3M -41.02% | 378.6M -17.77% | 460.4M -1.60% | 467.9M -20.75% | |
Operating Profit | -181.1M +62.21% | -111.7M -45.05% | -203.2M -20.90% | -256.9M -2.64% | |
Interest Income | 7.0M +55.56% | 4.5M +60.71% | 2.8M +47.37% | 1.9M +35.71% | |
Interest Expense | -9.0M -66.86% | -27.2M -33.01% | -40.5M +24.84% | -32.5M +41.44% | |
Interest Income and Expense and Net | -2.0M -91.17% | -22.7M -39.97% | -37.7M +23.44% | -30.6M +41.82% | |
Total Nonoperating Income and Expense | 7.0M +107.86% | 3.4M -38.33% | 5.5M +43.09% | 3.8M +1,450.53% | |
Income before Taxes | -183.1M -742.38% | 28.5M +111.96% | -238.3M -18.33% | -291.8M +1.62% | |
Income Taxes | 0 +100.00% | -380,000 0.00% | -380,000 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 168.0M +489.41% | 28.5M +111.98% | -237.9M -18.46% | -291.8M +1.62% | |
Net Income from Continuing Operations Applicable to Common | -183.1M -742.38% | 28.5M +111.96% | -238.3M -18.33% | -291.8M +1.62% | |
Basic EPS and Net Income | 1.43 +472.00% | 0.25 +109.88% | -2.53 -32.71% | -3.76 -1.31% | |
Diluted EPS and Net Income | 1.43 +472.00% | 0.25 +109.88% | -2.53 -32.71% | -3.76 -1.31% | |
Basic Weighted Average Shares | 117.1M +2.26% | 114.6M +21.65% | 94.2M +21.30% | 77.6M +2.89% | |
Diluted Weighted Average Shares | 117.1M +2.01% | 114.8M +21.95% | 94.2M +21.30% | 77.6M +2.89% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 88.9M -29.45% | 126.0M +22.45% | 102.9M +61.91% | 63.5M -84.77% | |
Short-Term Investments | 83.2M +460.32% | 14.9M 0.00% | 14.9M -88.41% | 128.1M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 172.1M +22.21% | 140.8M +19.61% | 117.7M -38.57% | 191.7M -54.05% | |
Total Current Assets | 206.7M -39.49% | 341.6M -28.18% | 475.6M +24.76% | 381.2M -36.71% | |
Accumulated Depreciation | N/A N/A | 21.0M +1.63% | 20.7M +473.64% | 3.6M -78.63% | |
Property and Plant and Equipment and Net | 1.3M -52.59% | 2.8M -44.58% | 5.1M -41.52% | 8.8M +12.04% | |
Total Long-Term Assets | 4.1M -39.43% | 6.7M -30.92% | 9.7M +11.74% | 8.7M -13.54% | |
Total Assets | 258.3M -42.40% | 448.5M -28.76% | 629.6M +30.94% | 480.8M -29.22% | |
Income Taxes Payable | 1.1M 0.00% | 1.1M 0.00% | 1.1M N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 140.4M -50.39% | 283.0M -14.71% | 331.8M +139.21% | 138.7M -16.11% | |
Total Long-Term Debt | 37.1M +0.96% | 36.7M -85.11% | 246.5M +0.41% | 245.5M +33.42% | |
Total Long-Term Liabilities | 18.4M -37.14% | 29.3M +133.49% | 12.6M +262.30% | 3.5M +362.27% | |
Total Liabilities | 197.3M -66.01% | 580.5M -29.47% | 823.0M +33.12% | 618.3M +6.30% | |
Retained Earnings | -1.4B -10.83% | -1.6B -1.80% | -1.6B +17.73% | -1.3B +27.79% | |
Total Stockholders Equity | 61.0M +146.23% | -132.0M -31.76% | -193.4M +40.76% | -137.4M -240.62% | |
Total Shares Outstanding | 121.2M +4.79% | 115.6M +3.03% | 112.2M +42.31% | 78.9M +2.50% | |
Cash Flow | |||||
Cash from Operating Activities | -138.5M +577.66% | -20.4M -88.31% | -174.9M -27.47% | -241.1M +544.17% | |
Capital Expenditures | N/A N/A | N/A N/A | 286,000 -85.97% | 2.0M +58.18% | |
Cash from Investing Activities | 375.1M +62.85% | 230.3M +59.24% | 144.6M +186.69% | -166.8M +20.55% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -273.7M +46.39% | -187.0M -368.64% | 69.6M +28.12% | 54.3M +4.72% | |
Financials Ratio | |||||
Gross Margin | 67.24% +20.15% | 55.97% +46.53% | 38.19% -42.82% | 66.79% -18.91% | |
Operating Margin | -429.51% +926.83% | -41.83% -47.05% | -78.99% -35.10% | -121.72% +50.64% | |
Return on Assets | 47.54% +798.98% | 5.29% +112.34% | -42.85% -14.81% | -50.29% +33.22% | |
Return on Equity | -473.47% +2,602.38% | -17.52% -112.18% | 143.81% -90.22% | 1,470.09% +1,069.56% | |
Revenue Growth | -84.20% -2,329.36% | 3.78% -82.75% | 21.89% +161.89% | -35.37% +12.75% | |
Current Ratio | 1.47 +21.98% | 1.21 -15.80% | 1.43 -47.84% | 2.75 -24.55% | |
Cash Ratio | 0.63 +42.21% | 0.45 +43.57% | 0.31 -32.32% | 0.46 -81.84% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow